NCT00465179 Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer Status COMPLETED Phase PHASE2
NCT00462982 Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma Status COMPLETED Phase PHASE2
NCT00459979 Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00459875 Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00445757 Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors Status WITHDRAWN Phase PHASE1
NCT00436410 Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer Status COMPLETED Phase EARLY_PHASE1
NCT00425386 Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00422344 A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE1
NCT00421512 A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients Status COMPLETED Phase PHASE1
NCT00416871 Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer Status COMPLETED Phase PHASE3
NCT00416429 Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer Status COMPLETED Phase PHASE3
NCT00405366 Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer Status COMPLETED Phase EARLY_PHASE1
NCT00403169 Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer Status COMPLETED Phase PHASE2
NCT00401128 Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00392821 Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00369564 Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Status COMPLETED Phase PHASE3
NCT00365768 Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors Status COMPLETED Phase PHASE2